A groundbreaking study from the Chinese Academy of Sciences (CAS) is challenging the conventional view that aging is an irreversible process. The research, led by scientists from CAS, presents new evidence suggesting that aging might not be as fixed as previously believed.
At the center of this study is metformin, a widely prescribed drug for type 2 diabetes. While primarily known for managing blood sugar, the researchers now believe that metformin could also slow the aging process itself. This discovery could pave the way for future treatments aimed at extending both lifespan and healthspan.
The research team, which included Liu Guanghui and Qu Jing from the Institute of Zoology, and Zhang Weiqi from the Beijing Institute of Genomics, published their findings in the prestigious journal Cell. Their study is part of a growing scientific interest in extending not just the length of life, but also the quality of life as people age.
To explore metformin’s effects on aging, the researchers conducted a study using Cynomolgus monkeys, whose biological similarities to humans make them ideal subjects for aging research. Over 40 months, the scientists closely monitored the monkeys’ health, employing advanced techniques such as medical imaging, blood tests, and tissue analysis across multiple organs. The male monkeys were regularly given metformin, allowing researchers to observe any long-term changes.
The results were impressive. Metformin showed protective effects in several key organs, including the liver, heart, lungs, and muscles, all of which exhibited signs of slower aging. These findings suggest that metformin could offer more than just blood sugar regulation—it might play a role in defending the body against the aging process itself.
The study also highlighted metformin’s ability to counteract brain aging. Notably, it slowed atrophy in the cerebral cortex, improved cognitive function, and reduced bone loss in the teeth, all signs that the drug might have a direct impact on brain cells, independent of its role in blood sugar regulation.
One of the key mechanisms identified was the activation of the Nrf2 antioxidant gene network in the brain, which helps delay the effects of cellular aging. This discovery supports the idea that metformin may have protective properties against aging, opening the door to potential therapies aimed at slowing down age-related changes.
In addition to studying the direct effects on neurons, the researchers used machine learning models to analyze the overall impact of metformin on aging. The models allowed them to assess the aging process across various tissues and organs, providing a more comprehensive understanding of the drug’s benefits.
The results were striking: high-precision aging clocks revealed that the biological age of brain and liver cells was reduced by about five to six years. When translated to human terms, this equates to a reduction of 15 to 18 years in biological age, a significant finding that underscores metformin’s potential to slow the aging process.
These results were particularly noticeable in the brain’s frontal lobe and the liver, two areas most vulnerable to aging. The study’s rigorous methodology provides new standards for assessing anti-aging interventions, marking a major advancement in the field.
As one of the lead scientists explained, “This is a significant step forward in understanding the biology of aging.” The research also signals a shift in geriatric medicine, where the focus is moving from treating individual chronic conditions to addressing aging as a whole. This paradigm shift could change the future of healthcare, targeting the root causes of aging to improve overall health and longevity.
With life expectancy continuing to rise, diseases related to aging, such as Alzheimer’s and heart conditions, are becoming increasingly common. However, this study suggests that targeting the aging process itself, rather than merely its effects, could offer a more effective approach to improving the health of older adults.
Looking ahead, further research into metformin’s potential could lead to broader applications for humans, helping to reduce age-related decline and enhance quality of life for older generations.
This study represents a major breakthrough in the understanding of aging, providing new insights into how it can be slowed and possibly even reversed. By expanding knowledge of cellular aging, scientists have laid the foundation for future therapies aimed at delaying the aging process, offering hope for a future where aging is not a decline, but a manageable process.
Related Topics:
